BDX Financials: Becton Dickinson and Co AI Analysis

Home

Stock

BDX

Financials

BDX Financial

Becton Dickinson and Co

$155.32

0.52%

$0.8

At close: Apr 06, 16:00:00 GMT-4

$155.9

0.37%

$0.58

Post-market: Apr 06, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$154.51

Open

$153.79

Day's Range

$152.98 - $155.93

52 week range

$127.53 - $187.35

Volume

1.8M

Avg.Volume

2.3M

Dividend yield

2.51%

EPS (TTM)

6.12

Market Cap

$44.3B

What is BDX?

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 74,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

BDX Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	09/30/2025	09/30/2024	09/30/2023	09/30/2022	09/30/2021
Revenue	21,924	21,840	20,178	19,372	18,870	19,131
Revenue Growth (YoY)	6%	8%	4%	3%	-1%	19%
Cost of Revenue	11,747	11,817	11,015	10,549	10,267	10,444
Gross Profit	10,177	10,023	9,163	8,823	8,603	8,687
Selling, General & Admin	5,352	5,278	4,857	4,719	4,709	4,719
Research & Development	1,227	1,235	1,190	1,237	1,256	1,279
Operating Expenses	6,593	6,514	6,257	6,000	5,983	6,360
Other Non Operating Income (Expenses)	-102	-57	-11	-66	-17	-7
Pretax Income	1,969	1,881	2,005	1,662	1,783	1,692
Income Tax Expense	212	203	300	132	148	88
Net Income	1,757	1,678	1,705	1,424	1,689	2,002
Net Income Growth	1%	-2%	20%	-16%	-16%	161%
Shares Outstanding (Diluted)	285.84	288.5	291	288.39	287	292
Shares Change (YoY)	-2%	-1%	1%	0%	-2%	4%
EPS (Diluted)	6.14	5.81	5.85	4.93	5.88	6.85
EPS Growth	2%	-1%	19%	-16%	-14%	153%
Free Cash Flow	2,631	2,670	3,073	2,115	1,661	3,452
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	46.41%	45.89%	45.41%	45.54%	45.59%	45.4%
Operating Margin	16.34%	16.06%	14.4%	14.57%	13.88%	12.16%
Profit Margin	8.01%	7.68%	8.44%	7.35%	8.95%	10.46%
Free Cash Flow Margin	12%	12.22%	15.22%	10.91%	8.8%	18.04%
EBITDA	6,053	5,971	5,192	5,111	4,849	4,557
EBITDA Margin	27.6%	27.33%	25.73%	26.38%	25.69%	23.81%
D&A For EBITDA	2,469	2,462	2,286	2,288	2,229	2,230
EBIT	3,584	3,509	2,906	2,823	2,620	2,327
EBIT Margin	16.34%	16.06%	14.4%	14.57%	13.88%	12.16%
Effective Tax Rate	10.76%	10.79%	14.96%	7.94%	8.3%	5.2%

Follow-Up Questions

What are Becton Dickinson and Co's key financial statements?



According to the latest financial statement (Form-10K), Becton Dickinson and Co has a total asset of $55,325, Net profit of $1,678

What are the key financial ratios for BDX?



Becton Dickinson and Co's Current ratio is 1.84, has a Net margin is 7.68, sales per share of $75.69.

How is Becton Dickinson and Co's revenue broken down by segment or geography?



Becton Dickinson and Co largest revenue segment is Medication Delivery Solutions, at a revenue of 4,575,000,000 in the most earnings release.For geography, United States is the primary market for Becton Dickinson and Co, at a revenue of 12,790,000,000.

Is Becton Dickinson and Co profitable?



yes, according to the latest financial statements, Becton Dickinson and Co has a net profit of $1,678

Does Becton Dickinson and Co have any liabilities?



yes, Becton Dickinson and Co has liability of 29,935

How many outstanding shares for Becton Dickinson and Co?



Becton Dickinson and Co has a total outstanding shares of 285.4

Becton Dickinson and Co (BDX) Financial

BDX Stock Price Chart